ESSENTIAL ROLE FOR INTERFERON-GAMMA AND INTERLEUKIN-6 IN AUTOIMMUNE INSULIN-DEPENDENT DIABETES IN NOD/WEHI MICE

被引:384
作者
CAMPBELL, IL [1 ]
KAY, TWH [1 ]
OXBROW, L [1 ]
HARRISON, LC [1 ]
机构
[1] ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,PARKVILLE,VIC 3050,AUSTRALIA
关键词
ANTI-CYTOKINE THERAPY; PANCREATIC ISLET; BETA-CELL;
D O I
10.1172/JCI115055
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Experimental studies in vitro suggest that cytokines are important mediators in the pathogenesis of autoimmune insulin-dependent diabetes mellitus (IDDM). However, there is little evidence for the role of cytokines in vivo, either in humans or in the spontaneous animal models of IDDM such as the NOD mouse or BB rat. To address this question, we used the model of cyclophosphamide (CYP)-induced autoimmune diabetes in the NOD/Wehi mouse to examine for (a) the production of IFN-gamma and IL-6 from isolated islets, and (b) the effect of anti IFN-gamma or anti IL-6 monoclonal antibodies on the development of diabetes. After cyclophosphamide, the majority of these mice develop of mononuclear cell infiltrate (insulitis) which by 10-14 d is associated with beta cell destruction. IFN-gamma-activity at low levels (2.7 +/- 0.3 U/ml) could be detected only in culture supernatants from islets isolated at day 7 post-cyclophosphamide. In contrast, IL-6 activity progressively increased from 457 +/- 44 U/ml at day 0 to 6,020 +/- 777 U/ml at day 10. Culture islets with anti-CD3 monoclonal antibody resulted in a significant increase in IFN-gamma-activity from 41 +/- U/ml at day 0 to 812 +/- 156 U/ml at day 10. Mice given either anti-IFN-gamma or anti-IL-6 antibody had a significant reduced (P < 0.001) incidence of diabetes and especially with IFN-gamma, decreased severity of insulitis. We conclude that IFN-gamma and IL-6 have essential roles in the pathogenesis of pancreatic islet beta cell destruction in this model.
引用
收藏
页码:739 / 742
页数:4
相关论文
共 33 条
[1]  
BACH JF, 1988, CLIN EXP IMMUNOL, V72, P1
[2]   COMPARISON OF HIGH-DIABETES-INCIDENCE AND LOW-DIABETES-INCIDENCE NOD MOUSE STRAINS [J].
BAXTER, AG ;
ADAMS, MA ;
MANDEL, TE .
DIABETES, 1989, 38 (10) :1296-1300
[3]   CYTOTOXICITY OF HUMAN PI-7 INTERLEUKIN-1 FOR PANCREATIC-ISLETS OF LANGERHANS [J].
BENDTZEN, K ;
MANDRUPPOULSEN, T ;
NERUP, J ;
NIELSEN, JH ;
DINARELLO, CA ;
SVENSON, M .
SCIENCE, 1986, 232 (4757) :1545-1547
[4]   INSITU CHARACTERIZATION OF AUTOIMMUNE PHENOMENA AND EXPRESSION OF HLA MOLECULES IN THE PANCREAS IN DIABETIC INSULITIS [J].
BOTTAZZO, GF ;
DEAN, BM ;
MCNALLY, JM ;
MACKAY, EH ;
SWIFT, PGF ;
GAMBLE, DR .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (06) :353-360
[5]  
CAMPBELL I L, 1990, Journal of Autoimmunity, V3, P53
[6]  
CAMPBELL IL, 1989, J IMMUNOL, V143, P1188
[7]  
CAMPBELL IL, 1990, MOL BIOL MED, V7, P299
[8]   INTERFERON-GAMMA ENHANCES THE EXPRESSION OF THE MAJOR HISTOCOMPATIBILITY CLASS-I ANTIGENS ON MOUSE PANCREATIC BETA-CELLS [J].
CAMPBELL, IL ;
WONG, GHW ;
SCHRADER, JW ;
HARRISON, LC .
DIABETES, 1985, 34 (11) :1205-1209
[9]  
CAMPBELL IL, 1988, J IMMUNOL, V141, P2325
[10]   INTERFERON-GAMMA INDUCES THE EXPRESSION OF HLA-A,B,C BUT NOT HLA-DR ON HUMAN PANCREATIC BETA-CELLS [J].
CAMPBELL, IL ;
BIZILJ, K ;
COLMAN, PG ;
TUCH, BE ;
HARRISON, LC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (06) :1101-1109